NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Centre for Clinical Practice at NICE (UK). Diabetic Foot Problems: Inpatient Management of Diabetic Foot Problems. London: National Institute for Health and Clinical Excellence (UK); 2011 Mar. (NICE Clinical Guidelines, No. 119.)

Cover of Diabetic Foot Problems

Diabetic Foot Problems: Inpatient Management of Diabetic Foot Problems.

Show details

Appendix DReferences of all included studies

Review question 1 and 2

Total number of studies retrieved from searches = 9817
Selection based on title and abstract = 318 (full papers ordered)Excluded = 9499
Selection based on full papers = 40Excluded = 278
Total number of studies included = 40

Review question 3, 4 and 5

Total number of studies retrieved from searches = 9817
Selection based on title and abstract = 320 (full papers ordered)Excluded = 9497
Selection based on full papers = 64Excluded = 256
Total number of studies included = 64

Review question 6

Total number of studies retrieved from searches = 9817
Selection based on title and abstract = 111 (full papers ordered)Excluded = 9706
Selection based on full papers = 0Excluded = 111
Total number of studies included = 0

Reference List

  • Afshari M, Larijani B, Fadayee M, et al. Efficacy of topical epidermal growth factor in healing diabetic foot ulcers. Therapy. 2005;2:759–65.
  • Al-Khawari HA, Al-Saeed OM, Jumaa TH, et al. Evaluating diabetic foot infection with magnetic resonance imaging: Kuwait experience. Medical Principles & Practice. 2005;14:165–72. [PubMed: 15863990]
  • Armstrong DG, Nguyen HC, Lavery LA, et al. Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care. 2001;24:1019–22. [Erratum appears in Diabetes Care 2001 Aug;24(8):1509] [PubMed: 11375363]
  • Beckert S, Witte M, Wicke C, et al. A new wound-based severity score for diabetic foot ulcers: A prospective analysis of 1,000 patients. Diabetes Care. 2006;29:988–92. [PubMed: 16644625]
  • Beltran J, Campanini DS, Knight C, et al. The diabetic foot: magnetic resonance imaging evaluation. Skeletal Radiology. 1990;19:37–41. [PubMed: 2326654]
  • Blume PA, Walters J, Payne W, et al. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care. 2008;31:631–6. [PubMed: 18162494]
  • Bouter KP, Visseren FLJ, Van Loenhout RMM, et al. Treatment of diabetic foot infection: An open randomised comparison of imipenem/cilastatin and piperacillin/clindamycin combination therapy. International Journal of Antimicrobial Agents. 1996;7:143–7. [PubMed: 18611748]
  • Boyko EJ, Ahroni JH, Davignon D, et al. Diagnostic utility of the history and physical examination for peripheral vascular disease among patients with diabetes mellitus. Journal of Clinical Epidemiology. 1997;50:659–68. [PubMed: 9250264]
  • Canavan RJ, Unwin NC, Kelly WF, et al. Diabetes- and nondiabetes-related lower extremity amputation incidence before and after the introduction of better organized diabetes foot care: continuous longitudinal monitoring using a standard method. Diabetes Care. 2008;31:459–63. [PubMed: 18071005]
  • Caravaggi C, Faglia E, De GR, et al. Effectiveness and safety of a nonremovable fiberglass off-bearing cast versus a therapeutic shoe in the treatment of neuropathic foot ulcers: a randomized study. Diabetes Care. 2000;23:1746–51. [PubMed: 11128345]
  • Caravaggi C, De GR, Faglia E. A multicenter, randomized controlled clinical trial to evaluate the efficacy of hyaluronan based dermal and epidermal autologous grafts in the treatment of diabetic foot ulcers. Diabetic Foot Study Group of the EASD. 2001:A30.
  • Caravaggi C, De GR, Pritelli C, et al. HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care. 2003;26:2853–9. [PubMed: 14514591]
  • Crane M, Werber B, Lavery LA. Critical pathway approach to diabetic pedal infections in a multidisciplinary setting. Journal of Foot and Ankle Surgery. 1999;38:82–3. [PubMed: 10028467]
  • Croll SD, Nicholas GG, Osborne MA, et al. Role of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections. Journal of Vascular Surgery. 1996;24:266–70. [PubMed: 8752038]
  • Dargis V, Pantelejeva O, Jonushaite A, et al. Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration: a prospective study. 7th Malvern Diabetic Foot Conference; 1998, 13-15 May; Malvern, UK. 1998. p. 23.
  • de LF, Pellizzer G, Strazzabosco M, et al. Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrobial Agents & Chemotherapy. 2001;45:1094–8. [PMC free article: PMC90429] [PubMed: 11257020]
  • Devillers A, Moisan A, Hennion F, et al. Contribution of technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy to the diagnosis of diabetic foot infection. European Journal of Nuclear Medicine. 1998;25:132–8. [PubMed: 9473260]
  • Doctor N, Pandya S, Supe A. Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine. 1992;38:112–4. [PubMed: 1303408]
  • Driver VR, Madsen J, Goodman RA. Reducing amputation rates in patients with diabetes at a military medical center: the limb preservation service model. Diabetes Care. 2005;28:248–53. [PubMed: 15677774]
  • Driver VR, Hanft J, Fylling CP, et al. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy/wound management. 2006;52:68–70. 72, 74. [PubMed: 16799184]
  • Duzgun AP, Satir HZ, Ozozan O, et al. Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot & Ankle Surgery. 2008;47:515–9. [PubMed: 19239860]
  • Edwards J, Stapley S. Debridement of diabetic foot ulcers. Cochrane Database of Systematic Reviews. 2010 [PubMed: 20091547]
  • Erstad BL, McIntyre J. Prospective, randomized comparison of ampicillin/sulbactam and cefoxitin for diabetic foot infections. Vascular Surgery. 1997;31:419–26.
  • Ertugrul BM, Savk O, Ozturk B, et al. The diagnosis of diabetic foot osteomyelitis: examination findings and laboratory values. Medical Science Monitor. 2009;15:CR307–CR312. [PubMed: 19478702]
  • Ertugrul MB, Baktiroglu S, Salman S, et al. The diagnosis of osteomyelitis of the foot in diabetes: microbiological examination vs. magnetic resonance imaging and labelled leucocyte scanning. Diabetic Medicine. 2006;23:649–53. [PubMed: 16759307]
  • Etoz A, Ozgenel Y, Ozcan M. The use of negative pressure wound therapy on diabetic foot ulcers: a preliminary controlled trial. Wounds: A Compendium of Clinical Research and Practice. 2004;16:264–9.
  • Faglia E, Favales F, Aldeghi A, et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care. 1996;19:1338–43. [PubMed: 8941460]
  • Fernandez-Montequin JI, Betancourt BY, Leyva-Gonzalez G, et al. Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure. International Wound Journal. 2009;6:67–72. [PubMed: 19291119]
  • Foster AVM, Greenhill MT, Edmonds ME. Comparing two dressings in the treatment of diabetic foot ulcers. Journal of Wound Care. 1994;3:224–8. [PubMed: 27922322]
  • Ganguly S, Chakraborty K, Mandal PK, et al. A comparative study between total contact casting and conventional dressings in the non-surgical management of diabetic plantar foot ulcers. Journal of the Indian Medical Association. 2008;106:237–9. +244. [PubMed: 18828342]
  • Gardener SE, Hillis SL, Frantz RA. Clinical signs of infection in diabetic foot ulcers with high microbial load. Biological Research for Nursing. 2009;11:119–28. [PMC free article: PMC2752486] [PubMed: 19147524]
  • Gentzkow G, Iwasaki S, Haynie K, et al. Decreased recurrence of healed diabetic foot ulcers treated with a cultured human dermis. 2nd Joint Meeting of the Wound Healing Society and the European Tissue Repair Society; 1996, 15-17 May; Boston MA. 1996. p. A128.
  • Gough A, Clapperton M, Rolando N, et al. Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. Lancet. 1997;350:855–9. [PubMed: 9310604]
  • Grayson ML, Gibbons GW, Habershaw GM, et al. Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clinical Infectious Diseases. 1994;18:683–93. [Erratum appears in Clin Infect Dis 1994 Oct;19(4):820] [PubMed: 8075257]
  • Grayson ML, Gibbons GW, Balogh K, et al. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA. 1995;273:721–3. [PubMed: 7853630]
  • Hardikar JV, Reddy YC, Bung DD, et al. Efficacy of recombinant human platelet-derived growth factor (rhPDGF) based gel in diabetic foot ulcers: a randomized, multicenter, double-blind, placebo-controlled study in India. Wounds: A Compendium of Clinical Research and Practice. 2005;17:141–52.
  • Harkless L, Boghossian J, Pollak R, et al. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers. Surgical Infections. 2005;6:27–40. [PubMed: 15865549]
  • Harvey J, Cohen MM. Technetium-99-labeled leukocytes in diagnosing diabetic osteomyelitis in the foot. Journal of Foot and Ankle Surgery. 1997;36:209–14. [PubMed: 9232501]
  • Harwood SJ, Valdivia S, Hung GL, et al. Use of Sulesomab, a radiolabeled antibody fragment, to detect osteomyelitis in diabetic patients with foot ulcers by leukoscintigraphy. Clinical Infectious Diseases. 1999;28:1200–5. [PubMed: 10451153]
  • Hughes CE, Johnson CC, Bamberger DM, et al. Treatment and long-term follow-up of foot infections in patients with diabetes or ischemia: a randomized, prospective, double-blind comparison of cefoxitin and ceftizoxime. Clinical Therapeutics. 1987;10 49 [PubMed: 3319172]
  • Jeffcoate WJ, Price PE, Phillips CJ, et al. Randomised controlled trial of the use of the three dressing preparations in the management of chronic ulceration of the foot in diabetes. Health Technology Assessment. 2009;13(54):1–110. [PubMed: 19922726]
  • Jude EB, Apelqvist J, Spraul M, et al. Prospective randomized controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers. Diabetic Medicine. 2007;24:280–8. [PubMed: 17305788]
  • Kalani M, Apelqvist J, Blomback M, et al. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study. Diabetes Care. 2003;26:2575–80. [PubMed: 12941721]
  • Kaleta JL, Fleischli JW, Reilly CH. The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate: a pilot study. Journal of the American Podiatric Medical Association. 2001;91:445–50. [PubMed: 11679625]
  • Kastenbauer T, Hornlein B, Sokol G, et al. Evaluation of granulocyte-colony stimulating factor (Filgrastim) in infected diabetic foot ulcers. Diabetologia. 2003;46:27–30. [PubMed: 12637979]
  • Katz IA, Harlan A, Miranda-Palma B, et al. A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care. 2005;28:555–9. [PubMed: 15735187]
  • Keenan AM, Tindel NL, Alavi A. Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Archives of Internal Medicine. 1989;149:2262–6. [PubMed: 2802892]
  • Kessler L, Bilbault P, Ortega F, et al. Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study. Diabetes Care. 2003;26:2378–82. [PubMed: 12882865]
  • Kreitner KF, Kalden P, Neufang A, et al. Diabetes and peripheral arterial occlusive disease: prospective comparison of contrast-enhanced three-dimensional MR angiography with conventional digital subtraction angiography. AJR American. 2000:171–9. [PubMed: 10628475]
  • Lapeyre M, Kobeiter H, Desgranges P, et al. Assessment of critical limb ischemia in patients with diabetes: comparison of MR angiography and digital subtraction angiography. AJR American. 2005:1641–50. [PubMed: 16304027]
  • Larcos G, Brown ML, Sutton RT. Diagnosis of osteomyelitis of the foot in diabetic patients: Value of <sup>111</sup>In-leukocyte scintigraphy. American Journal of Roentgenology. 1991;157:527–31. [PubMed: 1872240]
  • Larsson J, Apelqvist J, Agardh CD, et al. Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach? Diabetic Medicine. 1995;12:770–6. [PubMed: 8542736]
  • Levine SE, Neagle CE, Esterhai JL, et al. Magnetic resonance imaging for the diagnosis of osteomyelitis in the diabetic patient with a foot ulcer. Foot & Ankle International. 1994;15:151–6. [PubMed: 7951944]
  • Lipsky BA, Pecoraro RE, Larson SA, et al. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Archives of Internal Medicine. 1990;150:790–7. [PubMed: 2183732]
  • Lipsky BA, Baker PD, Landon GC, et al. Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens. Clinical Infectious Diseases. 1997;24:643–8. [PubMed: 9145738]
  • Lipsky BA, Itani K, Norden C, et al. Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. Clinical Infectious Diseases. 2004;38:17–24. [PubMed: 14679443]
  • Lipsky BA, Berendt AR, Embil J, et al. Diagnosing and treating diabetic foot infections. Diabetes/Metabolism Research and Reviews. 2004;20:S56–S64. [PubMed: 15150816]
  • Lipsky BA, Armstrong DG, Citron DM, et al. Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet. 2005;366:1695–703. [PubMed: 16291062]
  • Lipsky BA, Stoutenburgh U. Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections. Journal of Antimicrobial Chemotherapy. 2005;55:240–5. [PubMed: 15659542]
  • Lipsky BA, Giordano P, Choudhri S, et al. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate. Journal of Antimicrobial Chemotherapy. 2007;60:370–6. [PubMed: 17553812]
  • Lipsky BA, Holroyd KJ, Zasloff M. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clinical Infectious Diseases. 2008;47:1537–45. [PubMed: 18990064]
  • Malabu UH, Al-Rubeaan KA, Al-Derewish M. Diabetic foot osteomyelitis: usefulness of erythrocyte sedimentation rate in its diagnosis. West African Journal of Medicine. 2007;26:113–6. [PubMed: 17939311]
  • Marston WA, Hanft J, Norwood P, et al. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care. 2003;26:1701–5. [PubMed: 12766097]
  • Moretti B, Notarnicola A, Maggio G, et al. The management of neuropathic ulcers of the foot in diabetes by shock wave therapy. BMC Musculoskeletal Disorders. 2009;10:54. [PMC free article: PMC2693140] [PubMed: 19473538]
  • Morrison WB, Schweitzer ME, Wapner KL, et al. Osteomyelitis in feet of diabetics: clinical accuracy, surgical utility, and cost-effectiveness of MR imaging. Radiology. 1995;196:557–64. [PubMed: 7617877]
  • Mueller MJ, Diamond JE, Sinacore DR, et al. Total contact casting in treatment of diabetic plantar ulcers. Controlled clinical trial. Diabetes Care. 1989;12:384–8. [PubMed: 2659299]
  • Naughton G, Mansbridge J, Gentzkow G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artificial Organs. 1997;21:1203–10. [PubMed: 9384327]
  • Newman LG, Waller J, Palestro CJ, et al. Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. JAMA. 1991;266:1246–51. [PubMed: 1908030]
  • Newman LG, Waller J, Palestro CJ, et al. Leukocyte scanning with 111In is superior to magnetic resonance imaging in diagnosis of clinically unsuspected osteomyelitis in diabetic foot ulcers. Diabetes Care. 1992;15:1527–30. [PubMed: 1468281]
  • Niezgoda JA, Van Gils CC, Frykberg RG, et al. Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Advances in Skin & Wound Care. 2005;18:t-66. [PubMed: 15942317]
  • Oyibo SO, Jude EB, Tarawneh I, et al. A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care. 2001;24:84–8. [PubMed: 11194247]
  • Palestro CJ, Caprioli R, Love C, et al. Rapid diagnosis of pedal osteomyelitis in diabetics with a technetium-99m-labeled monoclonal antigranulocyte antibody. Journal of Foot & Ankle Surgery. 2003;42:2–8. [PubMed: 12567360]
  • Peters EJ, Lavery LA, Armstrong DG, et al. Electric stimulation as an adjunct to heal diabetic foot ulcers: a randomized clinical trial. Archives of Physical Medicine & Rehabilitation. 2001;82:721–5. [PubMed: 11387573]
  • Pham HT, Rosenblum BI, Lyons TE, et al. Evaluation of a human skin equivalent for the treatment of diabetic foot ulcers in a prospective, randomized, clinical trial. Wounds: A Compendium of Clinical Research and Practice. 1999;11:79–86.
  • Piaggesi A, Baccetti F, Rizzo L, et al. Sodium carboxyl-methyl-cellulose dressings in the management of deep ulcerations of diabetic foot. Diabetic Medicine. 2001;18:320–4. [PubMed: 11437864]
  • Poirier JY, Garin E, Derrien C, et al. Diagnosis of osteomyelitis in the diabetic foot with a <sup>99mTc</sup>-HMPAO leucocyte scintigraphy combined with a <sup>99mTc</sup>-MDP bone scintigraphy. Diabetes and Metabolism. 2002;28:485–90. [PubMed: 12522329]
  • Puttirutvong P. Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage. Journal of the Medical Association of Thailand. 2004;87:66–72. [PubMed: 14971537]
  • Remedios D, Valabhji J, Oelbaum R, et al. 99mTc-nanocolloid scintigraphy for assessing osteomyelitis in diabetic neuropathic feet. Clinical Radiology. 1998;53:120–5. [Review] [34 refs] [PubMed: 9502088]
  • Reyzelman A, Crews RT, Moore JC, et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. International Wound Journal. 2009;6:196–208. [PubMed: 19368581]
  • Robson MC, Hill DP, Woodske ME, et al. Wound healing trajectories as predictors of effectiveness of therapeutic agents. Archives of Surgery. 2000;135:773–7. [PubMed: 10896369]
  • Robson MC, Steed DL, McPherson JM, et al. Effects of transforming growth factor ÇY2 on wound healing in diabetic foot ulcers: a randomized controlled safety and dose-ranging trial. Journal of Applied Research. 2002;2:133–46.
  • Robson MC, Payne WG, Garner WL, et al. Integrating the results of phase IV (postmarketing) clinical trial with four previous trials reinforces the position that Regranex (becaplermin) Gel 0.01% is an effective adjunct to the treatment of diabetic foot ulcers. Journal of Applied Research. 2005;5:35–45.
  • Rozzanigo U, Tagliani A, Vittorini E, et al. Role of magnetic resonance imaging in the evaluation of diabetic foot with suspected osteomyelitis. Radiologia Medica. 2009;114:121–32. [PubMed: 18956147]
  • Rubello D, Casara D, Maran A, et al. Role of anti-granulocyte Fab' fragment antibody scintigraphy (LeukoScan) in evaluating bone infection: acquisition protocol, interpretation criteria and clinical results. Nuclear Medicine Communications. 2004;25:39–47. [PubMed: 15061263]
  • Shaw J, Hughes CM, Lagan KM, et al. An evaluation of three wound measurement techniques in diabetic foot wounds. Diabetes Care. 2007;30:2641–2. [PubMed: 17595352]
  • Shone A, Burnside J, Chipchase S, et al. Probing the validity of the probe-to-bone test in the diagnosis of osteomyelitis of the foot in diabetes. Diabetes Care. 2006;29:945–6. [PubMed: 16567847]
  • Shukrimi A, Sulaiman AR, Halim AY, et al. A comparative study between honey and povidone iodine as dressing solution for Wagner type II diabetic foot ulcers. Medical Journal of Malaysia. 2008;63:44–6. [PubMed: 18935732]
  • Slater RA, Lazarovitch T, Boldur I, et al. Swab cultures accurately identify bacterial pathogens in diabetic foot wounds not involving bone. Diabetic Medicine. 2004;21:705–9. [PubMed: 15209762]
  • Steed DL, Ricotta JJ, Prendergast JJ, et al. Promotion and acceleration of diabetic ulcer healing by arginine-glycine-aspartic acid (RGD) peptide matrix. RGD Study Group. Diabetes Care. 1995;18:39–46. [PubMed: 7698046]
  • Strauss MB, Aksenov IV. Evaluation of diabetic wound classifications and a new wound score. Clinical Orthopaedics & Related Research. 2005;439:79–86. [Review] [20 refs] [PubMed: 16205143]
  • Tan JS, Wishnow RM, Talan DA, et al. Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study Group. Antimicrobial Agents & Chemotherapy. 1993;37:1580–6. [PMC free article: PMC188023] [PubMed: 8215266]
  • Tsang MW, Wong WK, Hung CS, et al. Human epidermal growth factor enhances healing of diabetic foot ulcers. Diabetes Care. 2003;26:1856–61. [PubMed: 12766123]
  • Van De Weg FB, Van Der Windt DA, Vahl AC. Wound healing: total contact cast vs. custom-made temporary footwear for patients with diabetic foot ulceration. Prosthetics & Orthotics International. 2008;32:3–11. [PubMed: 17943623]
  • Veves A, Falanga V, Armstrong DG, et al. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care. 2001;24:290–5. [PubMed: 11213881]
  • Veves A, Sheehan P, Pham HT. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Archives of Surgery. 2002;137:822–7. [PubMed: 12093340]
  • Viswanathan V, Mahesh U, Jayaraman M, et al. Beneficial role of granulocyte colony stimulating factor in foot infection in diabetic patients. Journal of the Association of Physicians of India. 2003;51:90–1. [PubMed: 12693475]
  • Viswanathan V, Pendsey S, Sekar N, et al. A phase III study to evaluate the safety and efficacy of recombinant human epidermal growth factor (REGEN-D 150) in healing diabetic foot ulcers. Wounds: A Compendium of Clinical Research and Practice. 2006;18:186–96.
  • Wang A, Weinstein D, Greenfield L, et al. MRI and diabetic foot infections. Magnetic Resonance Imaging. 1990;8:805–9. [PubMed: 2266808]
  • Weinstein D, Wang A, Chambers R, et al. Evaluation of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections. Foot & Ankle. 1993;14:18–22. [PubMed: 8425726]
  • Wieman TJ. Clinical efficacy of becaplermin (rhPDGF-BB) gel. American Journal of Surgery. 1998;176:74S–9S. [PubMed: 9777976]
  • Williams DT, Maegele M, Gregor S, et al. Negative pressure therapy in diabetic foot wounds… Lancet. 2006;367:725–8. Armstrong DG, Lavery LA et al. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 2005;366:1704-10. [PubMed: 16517264]
  • Yonem A, Cakir B, Guler S, et al. Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection. Diabetes, Obesity & Metabolism. 2001;3:332–7. [PubMed: 11703423]
Copyright © 2011, National Institute for Health and Clinical Excellence.

All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of NICE.

Bookshelf ID: NBK82339


  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (4.6M)

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...